Anteris Technologies Ltd
ASX:AVR
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
8.8
23.55
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Anteris Technologies Ltd
Anteris Technologies Ltd
Cash & Cash Equivalents
Anteris Technologies Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Anteris Technologies Ltd
ASX:AVR
|
Cash & Cash Equivalents
AU$30.8m
|
CAGR 3-Years
94%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
|
Nanosonics Ltd
ASX:NAN
|
Cash & Cash Equivalents
AU$23.5m
|
CAGR 3-Years
1%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
|
Polynovo Ltd
ASX:PNV
|
Cash & Cash Equivalents
AU$45.9m
|
CAGR 3-Years
81%
|
CAGR 5-Years
27%
|
CAGR 10-Years
55%
|
|
|
SDI Ltd
ASX:SDI
|
Cash & Cash Equivalents
AU$6.3m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
5%
|
|
|
Ansell Ltd
ASX:ANN
|
Cash & Cash Equivalents
$185.5m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-5%
|
|
|
Next Science Ltd
ASX:NXS
|
Cash & Cash Equivalents
$9.2m
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
Anteris Technologies Ltd
Glance View
Anteris Technologies Ltd. is a structural heart company, researches, develops, commercializes, and distributes various medical technologies and devices. The company is headquartered in Toowong, Queensland. The company went IPO on 2004-03-24. The firm is engaged in delivering solutions that help healthcare professionals. The firm operates through two segments: operations and projects. Operation segment provides Bio implant ADAPT operations inclusive of manufacturing and sales. Project segment includes Transcatheter Aortic Valve Replacement (TAVR), which is developed using ADAPT 3D single-piece technology and other development projects across the Company. The company offers two products, ADAPT and DurAVR. ADAPT technology is a BioScaffold, which is a tissue technology platform that demonstrates zero calcification. xenograft tissue into a pure collagen scaffold with optimized strength and pliability, biocompatibility and unparalleled durability. DurAVR heart valve Is focused on delivering a functional cure in the treatment of Severe Aortic Stenosis.
See Also
What is Anteris Technologies Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
30.8m
AUD
Based on the financial report for Dec 31, 2023, Anteris Technologies Ltd's Cash & Cash Equivalents amounts to 30.8m AUD.
What is Anteris Technologies Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
36%
Over the last year, the Cash & Cash Equivalents growth was 123%. The average annual Cash & Cash Equivalents growth rates for Anteris Technologies Ltd have been 94% over the past three years , 36% over the past five years .
You don't have any saved screeners yet
